Ami Asset Management Corp Madrigal Pharmaceuticals, Inc. Transaction History
Ami Asset Management Corp
- $1.7 Billion
- Q2 2025
A detailed history of Ami Asset Management Corp transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Ami Asset Management Corp holds 3,440 shares of MDGL stock, worth $1.03 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
3,440
Previous 5,500
37.45%
Holding current value
$1.03 Million
Previous $1.82 Million
42.83%
% of portfolio
0.06%
Previous 0.11%
Shares
7 transactions
Others Institutions Holding MDGL
# of Institutions
367Shares Held
23.2MCall Options Held
979KPut Options Held
459K-
Janus Henderson Group PLC London, X02.21MShares$658 Million0.42% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.1MShares$626 Million39.89% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.02MShares$603 Million10.84% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$595 Million10.82% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$589 Million7.8% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.1B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...